BIDU Medical's trading volume on March 6 was $440 million, ranking 308th among U.S. stocks on that day.

On March 6, 2026, medical device company Becton Dickinson (BDX) had a trading volume of $440 million, ranking 308th among U.S. stocks for the day, a decrease of 9.04% from yesterday, with a trading volume of 2.6334 million shares.

Becton Dickinson (BDX) fell 1.66% on March 6, 2026, to $167.12. The stock has declined 5.30% over the past five trading days, 5.30% for the entire March, down 13.89% year-to-date, and down 25.84% over the past 52 weeks.

If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to now (this also applies to listings less than 1 month or fewer than 5 trading days).

Becton Dickinson released its Q1 FY2026 earnings report on February 9, 2026. Revenue from October 1, 2025, to December 31, 2025, was $5.25B, a year-over-year increase of 1.63%, with a net profit of $382 million, up 26.07% year-over-year.

Becton Dickinson Medical Devices Ltd. was incorporated in November 1906 under New Jersey law. The company is a global medical technology firm engaged in the development, manufacturing, and sale of various medical supplies, equipment, laboratory devices, and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the public. The company provides customer solutions focused on improving drug management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; assisting anesthesia care; enhancing infectious disease and cancer diagnostics; promoting cell research and applications; and supporting diabetes management.